News

The definitive acquisition agreement contemplates that China Aoxing will acquire 100% ownership of Shijiazhuang Lerentang. The purchase price will be paid approximately $10.8 million in cash and eight

This agreement resulted from the strategic alliance entered into by Tacere and Oncolys in June 2007, whereby Oncolys was granted an option to acquire the Asian rights for

The partnership will focus on the distribution of medical surgical products and services in 10 states. This three-year agreement creates a partnership of shared responsibility to ensure Amerinet

The Xcelerant Hydro Delivery System features a uniquely integrated sheath that contributes to the system’s low profile characteristics, which are intended to enable excellent tracking and access through

ImmuCell granted Anadis an exclusive, worldwide license to the human and environmental applications of its milk antibody technology. Under this agreement, ImmuCell is not obligated to fund further

The trial compared the pharmacokinetic (PK) profile of L-Dopa (levodopa) produced by a single oral dose of a prototype, sustained-release tablet of XP21279 to that of a near-equivalent

Paclitaxel injection is a generic version of Bristol-Myers Squibb’s Taxol (paclitaxel) injection USP, 6mg/mL, packaged in 100mg/16.7mL and 300mg/50mL multiple-dose vials.

The trial is a randomized, double-blinded, dummy-controlled study designed to evaluate the efficacy and safety of ThermoDox in combination with radiofrequency ablation (RFA) compared to RFA-alone. This 40

This study, which achieved all of its planned objectives, primarily measured the ability of Unigene’s proprietary oral delivery technology to significantly reduce the levels of an established biochemical